The present disclosure relates to compounds of formula I useful as agonists of cannabinoid receptors. The disclosure also provides pharmaceutically acceptable compositions comprising the compounds of the disclosure and methods of using the compositions in the treatment of various disorders.
本公开涉及到I式化合物,其作为
大麻素受体激动剂具有应用价值。本公开还提供了包含所述化合物的药学上可接受的组合物,并提供了使用这些组合物治疗各种疾病的方法。